The neuro-ocular effects of long-duration spaceflight have been termed Spaceflight Associated Neuro-Ocular Syndrome (SANS) and are a potential challenge for future, human space exploration. The underlying pathogenesis of SANS remains ill-defined, but several emerging translational applications of terrestrial head-mounted, visual assessment technology and machine learning frameworks are being studied for potential use in SANS. To develop such technology requires close consideration of the spaceflight environment which is limited in medical resources and imaging modalities. This austere environment necessitates the utilization of low mass, low footprint technology to build a visual assessment system that is comprehensive, accessible, and efficient. In this paper, we discuss the unique considerations for developing this technology for SANS and translational applications on Earth. Several key limitations observed in the austere spaceflight environment share similarities to barriers to care for underserved areas on Earth. We discuss common terrestrial ophthalmic diseases and how machine learning and visual assessment technology for SANS can help increase screening for early intervention. The foundational developments with this novel system may help protect the visual health of both astronauts and individuals on Earth.

Bard AI, developed by Google, represents a significant advancement in the realm of artificial intelligence (AI) powered chatbots [1]. This innovative AI is designed to simulate human-like interactions, answering a wide array of user inquiries and prompts [1]. Having been trained on a vast dataset of text data, Bard utilizes sophisticated language models to generate comprehensive and informative responses to user inputs [1]. The mechanism behind Bard involves its large language model, specifically the Pathways Language Model 2 (PaLM 2), which has been engineered to excel in comprehending facts, logical reasoning, and mathematics [1]. The capacity of the model to effectively analyze and comprehend contextual information enables it to deliver comprehensive and precise responses to a wide array of inquiries [1, 2]. While Bard shares some similarities with ChatGPT, Bard AI distinguishes itself through its emphasis on factual accuracy. Bard demonstrates exceptional proficiency in understanding and answering questions that require precise information [1]. In contrast, ChatGPT, a generative language model, is proficient in generating creative and diverse types of text, such as articles, code, scripts, and more which may or may not be completely accurate [3]. One of the fundamental differences between Bard AI and ChatGPT lies in their data sources and connections to the internet. Bard AI is linked to Google's expansive search network, granting it access to real-time information from the internet [1]. This allows Bard AI to provide up-to-date information about current events and topics [1]. On the other hand, ChatGPT is not directly connected to the internet, and leverages data up to 2021 to generate its responses [3, 4]. ChatGPT has already shown considerable potential in the field of ophthalmology, from helping triage ophthalmic symptoms [5], medical education [6], answering ophthalmic board certification practice questions [7], writing cataract surgery operative notes [8], developing ophthalmology AI algorithms to classify OCT images [9]. The utilization of Bard AI has considerable potential upside and downside for ophthalmology. The ability of Bard AI to comprehend and provide factual information makes it a valuable tool for